ClassID:

109145

C12N2310/14 - page 21 - CPC Classification

Classification description:

Structure or type of the nucleic acid; Type of nucleic acid interfering N.A.

Recent Application in this class:
#6001
20150164053
2015-06-18

Mammal with an orthotopic tumor capable of metastasis, a method of making and a method of using

#6002
20150159216
2015-06-11

METHODS AND COMPOSITIONS RELATED TO THE SMCHD1 GENE

#6003
20150159163
2015-06-11

Modified nucleosides, analogs thereof and oligomeric compounds prepared therefrom

#6004
20150159162
2015-06-11

Treatment of tumor suppressor gene related diseases by inhibition of natural antisense transcript to the gene

#6005
20150159156
2015-06-11

Compositions and methods for controlling arthropod parasite and pest infestations

#6006
20150159154
2015-06-11

Oligonucleotide compounds comprising non-nucleotide overhangs

#6007
20150157692
2015-06-11

METHODS OF TREATING OBESITY

#6008
20150157686
2015-06-11

Treatments of oxidative stress conditions

#6009
20150157662
2015-06-11

Generation of human induced pluripotent stem cells using nucleic acid sequences that inhibit Δ-NP63 and DGCR8

#6010
20150157547
2015-06-11

Skin lightening composition

#6011
20150152435
2015-06-04

Method for expression of small RNA molecules within a cell

#6012
20150152424
2015-06-04

Treatment of pyrroline-5-carboxylate reductase 1 (PYCR1) related diseases by inhibition of natural antisense transcript to PYCR1

#6013
20150152421
2015-06-04

HEXIM-1 AS A TARGET OF LEPTIN SIGNALING TO REGULATE OBESITY AND DIABETES

#6014
20150152417
2015-06-04

Treatment of filaggrin (FLG) related diseases by modulation of FLG expression and activity

#6015
20150152414
2015-06-04

Chemical modification of short small hairpin RNAs for inhibition of gene expression

#6016
20150152412
2015-06-04

siRNA compounds comprising terminal substitutions

#6017
20150152175
2015-06-04

THERAPIES FOR CANCER USING RLIP76

#6018
20150152171
2015-06-04

Modulation of TLR4-signaling pathway

#6019
20150150899
2015-06-04

Isoform of Bruton's Tyrosine Kinase (BTK) Protein

#6020
20150150803
2015-06-04

AEROSOL DELIVERY SYSTEMS, COMPOSITIONS AND METHODS

#6021
20150148530
2015-05-28

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

#6022
20150148529
2015-05-28

NUCLEIC ACID COMPLEX AND NUCLEIC ACID-POLYSACCHARIDE COMPLEX

#6023
20150148527
2015-05-28

Sugar chain-containing polymer, and sugar chain-containing polymer complex

#6024
20150148403
2015-05-28

USP37 inactivation as a treatment for PLZF/RARA-associated acute promyelocytic leukemia

#6025
20150148401
2015-05-28

Methods and compositions for inhibiting the growth and/or proliferation of MYC-driven tumor cells

#6026
20150147270
2015-05-28

Constructs for diagnosing and treating inflammatory bowel diseases and colon cancer

#6027
20150143580
2015-05-21

Compositions and methods for controlling leptinotarsa

#6028
20150141678
2015-05-21

Ionizable cationic lipid for RNA delivery

#6029
20150141575
2015-05-21

Charge conversional ternary polyplex

#6030
20150141492
2015-05-21

RNA interference mediating small RNA molecules

#6031
20150141491
2015-05-21

Therapeutic targets for Alzheimer's disease

#6032
20150141489
2015-05-21

Methods of treating and diagnosing diseases using agents that regulate the alternative splicing pathway

#6033
20150141488
2015-05-21

Small molecule inhibitors of RNA binding motif (RBM) proteins for the treatment of acute cellular injury

#6034
20150141487
2015-05-21

Oligoribonucleotides and methods of use thereof for treatment of alopecia, acute renal failure and other diseases

#6035
20150141348
2015-05-21

Sustained release siRNA for ocular drug delivery

#6036
20150140124
2015-05-21

Method of diagnosing, treating and determining progression and survival of cancer cells using BCL-2 antagonist of cell death (BAD) pathway gene signature

#6037
20150140108
2015-05-21

Lipidated glycosaminoglycan particles for the delivery of nucleic acids

#6038
20150140010
2015-05-21

METHODS FOR DIAGNOSING AND TREATING FOCAL SEGMENTAL GLOMERULOSCLEROSIS

#6039
20150140009
2015-05-21

COMPOSITIONS AND METHODS FOR THE TREATMENT OF RADIATION EXPOSURE

#6040
20150140008
2015-05-21

USES OF CXCL17, A NOVEL CHEMOKINE MARKER OF HUMAN LUNG AND GASTROINTESTINAL DISEASE

#6041
20150140005
2015-05-21

Methods and Uses for Proprotein Convertase Subtilisin Kexin 9 (PCSK9) Inhibitors

#6042
20150135363
2015-05-14

Compositions and methods for the control of root lesion nematode

#6043
20150133532
2015-05-14

Compositions for controlling mites in bees

#6044
20150133525
2015-05-14

Treatment of RNASE H1 related diseases by inhibition of natural antisense transcript to RNASE H1

#6045
20150133524
2015-05-14

PYRUVATE DEHYROGENASE KINASES AS THERAEUTIC TARGETS FOR CANCER AND ISCHEMIC DISEASES

#6046
20150133523
2015-05-14

METHOD FOR DOWN-REGULATING GENE EXPRESSION IN FUNGI

#6047
20150133520
2015-05-14

Compositions and methods for inducing myoblast differentiation and myotube formation

#6048
20150133519
2015-05-14

Diester and triester based low molecular weight, biodegradeable cationic lipids for oligonucleotide delivery

#6049
20150132848
2015-05-14

High complexity siRNA pools

#6050
20150132761
2015-05-14

Method for rapidly evaluating performance of short interfering RNA with novel chemical modifications

#6051
20150132370
2015-05-14

Composition and methods for reduced scarring and treatment of fibrosis

#6052
20150132321
2015-05-14

METHODS OF MODULATING ANGIOGENESIS VIA TRPV4

#6053
20150132226
2015-05-14

TREATMENT OF CANCER

#6054
20150128303
2015-05-07

Transgenic plant-based methods for plant pests using RNAI

#6055
20150126586
2015-05-07

Combination therapy for treating hearing and balance disorders

#6056
20150126583
2015-05-07

Reducing galectin-12 activity to influence the cell function of human sebocytes

#6057
20150126564
2015-05-07

Modulation of sphingosine 1-phosphate metabolizing enzymes for the treatment of negative-strand RNA virus infections

#6058
20150126496
2015-05-07

Diagnosis of autism spectrum disorders and its treatment with an antagonist or inhibitor of the 5-HT2c receptor signaling pathway

#6059
20150126387
2015-05-07

AMPK activator screening method, and AMPK activator

#6060
20150125516
2015-05-07

Transferrin receptor aptamers and aptamer-targeted delivery

#6061
20150125456
2015-05-07

COLON DISEASE TARGETS AND USES THEREOF

#6062
20150119451
2015-04-30

Treatment of interferon regulatory factor 8 (IRF8) related diseases by inhibition of natural antisense transcript to IRF8

#6063
20150119448
2015-04-30

RNA products and uses thereof

#6064
20150119446
2015-04-30

CUL4B as predictive biomarker for cancer treatment

#6065
20150118746
2015-04-30

Influenza virus reassortment method

#6066
20150118713
2015-04-30

Method for constructing functional nucleic acid molecule, and nucleic acid combination to be used in said method

#6067
20150118682
2015-04-30

Methods for producing interfering RNA molecules in mammalian cells and therapeutic uses for such molecules

#6068
20150118288
2015-04-30

Lipid nanoparticle compositions and methods of making and methods of using the same

#6069
20150113682
2015-04-23

Methods and compositions for root knot nematode control

#6070
20150113670
2015-04-23

Compositions and Methods for Inhibiting Expression of RRM2 Genes

#6071
20150111952
2015-04-23

Method for treating glioma using Tarbp2 expression inhibitor

#6072
20150111950
2015-04-23

Inhibition of DNA2 in fanconi anemia

#6073
20150111948
2015-04-23

RNA-interference-inducing nucleic acid molecule able to penetrate into cells, and use therefor

#6074
20150111947
2015-04-23

Compositions and methods for decreasing leukocyte extravasation and vessel fluid leakage

#6075
20150111945
2015-04-23

Compositions and methods for silencing ebola virus gene expression

#6076
20150111841
2015-04-23

Compositions and methods for inhibiting expression of the ALAS1 gene

#6077
20150110877
2015-04-23

Cancer therapeutics

#6078
20150110876
2015-04-23

Composition for gene delivery

#6079
20150110861
2015-04-23

Compositions and methods for siRNA inhibition of angiogenesis

#6080
20150110860
2015-04-23

Methods and compositions for the specific inhibition of gene expression by double-stranded RNA

#6081
20150105545
2015-04-16

Interfering RNA molecules

#6082
20150105544
2015-04-16

Polynucleotide comprising sequences of wheat gliadins and use thereof for silencing by RNAi

#6083
20150105451
2015-04-16

Treatment of Paraoxonase 1 (PON1) related diseases by inhibition of natural antisense transcript to PON1

#6084
20150105450
2015-04-16

Multi-targeting short interfering RNAs

#6085
20150105448
2015-04-16

MEANS AND METHODS FOR THE SPECIFIC MODULATION OF TARGET GENES IN THE CNS AND THE EYE AND METHODS FOR THEIR IDENTIFICATION

#6086
20150105447
2015-04-16

Fidgetin-like 2 as a target to enhance wound healing

#6087
20150105445
2015-04-16

RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC ACID (siNA)

#6088
20150105443
2015-04-16

Single-stranded nucleic acid molecule for regulating expression of gene having delivering function

#6089
20150105441
2015-04-16

LIM kinasemodulating agents for neurofibromatoses therapy and methods for screening for same

#6090
20150105327
2015-04-16

Compositions and methods for the treatment of VprBP-related cancers

#6091
20150099794
2015-04-09

GNAQ targeted dsRNA compositions and methods for inhibiting expression

#6092
20150099793
2015-04-09

Rational design of microRNA-siRNA chimeras for multi-functional target suppression

#6093
20150099790
2015-04-09

COMPOSITIONS AND METHODS FOR MODULATING MITOCHONDRIAL PYRUVATE CARRIER ACTIVITY

#6094
20150098952
2015-04-09

NOVEL THERAPEUTIC TARGET AND DIAGNOSTIC MARKER FOR ASTHMA AND RELATED CONDITIONS

#6095
20150098926
2015-04-09

Methods of Treating Hepatitis C Virus Infection

#6096
20150096065
2015-04-02

Method of regulating gene expression

#6097
20150096064
2015-04-02

RNA-interference by single-stranded RNA molecules

#6098
20150094358
2015-04-02

Treatment of hepatocyte growth factor (HGF) related diseases by inhibition of natural antisense transcript to HGF

#6099
20150094355
2015-04-02

Modulation of NLGn4 expression, NK cell activity in non-alcoholic fatty liver disease (NAFLD)

#6100
20150094354
2015-04-02

METHOD FOR TREATING CELL PROLIFERATIVE DISORDER BY INHIBITING C1GALT1 EXPRESSION

#6101
20150093444
2015-04-02

Block copolymer, liquid composite thereof, nucleic acid preparation, preparation methods therefor, and use thereof

#6102
20150087696
2015-03-26

METHOD OF CONTROLLING INITIAL DRUG RELEASE OF siRNA FROM SUSTAINED-RELEASE IMPLANTS

#6103
20150087694
2015-03-26

MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF TUMOR INVOLVING CHROMOSOMAL REARRANGEMENTS

#6104
20150087693
2015-03-26

Micro-RNAs involved in macular degeneration

#6105
20150087690
2015-03-26

G protein-coupled purinergic receptor Gpr17 mediates orexigenic effects of FoxO1 in AgRP neurons

#6106
20150087689
2015-03-26

COMPOSITIONS AND METHODS FOR EFFICACIOUS AND SAFE DELIVERY OF siRNA USING SPECIFIC CHITOSAN-BASED NANOCOMPLEXES

#6107
20150086613
2015-03-26

Lipid-derived neutral nanoparticles

#6108
20150086565
2015-03-26

Cancer-related extracellular matrix signatures and related methods and products

#6109
20150082490
2015-03-19

Glycaspis Brimblecombei Control Agents

#6110
20150082482
2015-03-19

Bronze bug control agents

#6111
20150080320
2015-03-19

MULTI-TARGET MODULATION FOR TREATING FIBROSIS AND INFLAMMATORY CONDITIONS

#6112
20150080315
2015-03-19

Spalt-like transcription factor 4 (SALL4) and uses thereof

#6113
20150079634
2015-03-19

Reduction of formation of amidated amino acids in cell lines for protein expression

#6114
20150079161
2015-03-19

Method for selectively inhibiting ACAT1 in the treatment of neurodegenerative diseases

#6115
20150079108
2015-03-19

Method for treatment of diabetes by a small molecule inhibitor for GRK5

#6116
20150079107
2015-03-19

Agents and methods for treating and preventing seborrheic keratosis

#6117
20150079106
2015-03-19

ANTI-NEOPLASTIC USES OF ARTEMIN ANTAGONISTS

#6118
20150073133
2015-03-12

iRNA agents with biocleavable tethers

#6119
20150073124
2015-03-12

Micro-RMA inhibitor

#6120
20150073040
2015-03-12

Treatment of down syndrome gene related diseases by inhibition of natural antisense transcript to a down syndrome gene

#6121
20150073039
2015-03-12

Preventing or treating viral infection using an inhibitor of the LSD1 protein, a MAO inhibitor or an inhibitor of LSD1 and a MAO inhibitor

#6122
20150073038
2015-03-12

DELIVERY MOLECULES FOR THERAPEUTICS

#6123
20150073036
2015-03-12

NOVEL NTRK1 FUSION MOLECULES AND USES THEREOF

#6124
20150073034
2015-03-12

Methods and pharmaceutical compositions for the treatment of hypertension

#6125
20150073033
2015-03-12

BIOMARKERS FOR CANCER CHARACTERIZATION AND TREATMENT

#6126
20150072893
2015-03-12

Methods for genome-wide screening and construction of genetic interaction maps

#6127
20150072347
2015-03-12

Methods and kits for synthesis of siRNA expression cassettes

#6128
20150071999
2015-03-12

RNAi molecule delivery platform based on single-siRNA and shRNA nanocapsules

#6129
20150071933
2015-03-12

Use of annexin A3 as a diagnostic and prognostic biomarker and therapeutic target for treating hepatocellular carcinoma

#6130
20150071931
2015-03-12

LM-antibodies, functional fragments, LM-1 target antigen, and methods for making and using same

#6131
20150071930
2015-03-12

Combination therapy using c-Met inhibitor and beta-catenin inhibitor

#6132
20150071855
2015-03-12

EGFL7 targeting and/or binding polypeptides and methods for inhibiting angiogenesis

#6133
20150065561
2015-03-05

Compositions and methods for treating otitis media and other conditions with inhibitors of CYLD

#6134
20150065559
2015-03-05

METHODS FOR DELIVERY OF siRNA TO THE SPINAL CORD AND THERAPIES ARISING THEREFROM

#6135
20150065558
2015-03-05

Glycoconjugates of RNA interference agents

#6136
20150065557
2015-03-05

Methods for controlling pests using RNAi

#6137
20150065556
2015-03-05

THERAPEUTIC TARGETS FOR MITOCHONDRIAL DISORDERS

#6138
20150065555
2015-03-05

Methods and compositions for the specific inhibition of MCL1 by double-stranded RNA

#6139
20150065554
2015-03-05

Neurofibromatoses therapeutic agents and screening for same

#6140
20150065518
2015-03-05

Methods of treating cancer having an active Wnt/β-catenin pathway

#6141
20150065432
2015-03-05

Visfatin therapeutic agents for the treatment of acne and other conditions

#6142
20150065431
2015-03-05

REDUCING CUTANEOUS SCAR FORMATION AND TREATING SKIN CONDITIONS

#6143
20150064710
2015-03-05

METHOD FOR INHIBITING CELL GROWTH, NUCLEIC ACID MOLECULE HAVING RNA INTERFERENCE EFFECT ON NEK10 VARIANT GENE, AND ANTICANCER AGENT

#6144
20150064242
2015-03-05

Trialkyl cationic lipids and methods of use thereof

#6145
20150057339
2015-02-26

High molecular weight arginine-grafted bioreducible polymers

#6146
20150057337
2015-02-26

Methods and compositions for the specific inhibition of KRAS by asymmetric double-stranded RNA

#6147
20150057336
2015-02-26

RNAi-RELATED INHIBITION OF TNF alpha SIGNALING PATHWAY FOR TREATMENT OF GLAUCOMA

#6148
20150057335
2015-02-26

NOVEL FUSION GENES IDENTIFIED IN LUNG CANCER

#6149
20150057334
2015-02-26

USE OF INHIBITORS OF ZDHHC2 ACTIVITY FOR MODULATION OF ADIPOGENESIS

#6150
20150057333
2015-02-26

Double-stranded oligonucleotides

#6151
20150057332
2015-02-26

Methods for the treatment of nonalcoholic steatohepatitis

#6152
20150057331
2015-02-26

Cellular targets for HIV infection

#6153
20150057164
2015-02-26

HIGH THROUGHPUT METHODS FOR FUNCTIONALLY DETERMINING RNA INTERFERENCE EFFICIENCY

#6154
20150056215
2015-02-26

Methods of treating proliferative disorders with malate or derivatives thereof

#6155
20150056192
2015-02-26

Compositions of combinations of non-covalent DNA binding agents and anti-cancer and/or anti-inflammatory agents and their use in disease treatment

#6156
20150056158
2015-02-26

BRANCHED POLYMERS

#6157
20150052643
2015-02-19

Compositions and methods for insecticidal control of stinkbugs

#6158
20150051265
2015-02-19

Dually derivatized chitosan nanoparticles and methods of making and using the same

#6159
20150051264
2015-02-19

INHIBITORS OF NOX4 EXPRESSION AND /OR NOX4 FUNCTION AND THEIR USE IN THE PREVENTION AND TREATMENT OF NERVE INJURY AND/OR NEUROPATHIC PAIN

#6160
20150050347
2015-02-19

Reverse micelle system comprising nucleic acids and use thereof

#6161
20150050341
2015-02-19

Methods and compositions for RNAi-based cancer treatment

#6162
20150050328
2015-02-19

Methods for treating eye disorders

#6163
20150050294
2015-02-19

Methods for diagnosing and treating neuroendocrine cancer

#6164
20150050285
2015-02-19

Combination therapy for cancer using HSP27 inhibitor and EGFR tyrosine kinase inhibitors or anti-folates

#6165
20150047063
2015-02-12

Delivery of dsRNA to arthropods

#6166
20150045546
2015-02-12

RNA-directed DNA cleavage by the Cas9-crRNA complex

#6167
20150045413
2015-02-12

RNA Modulating Oligonucleotides with Improved Characteristics for the Treatment of Duchenne and Becker Muscular Dystrophy

#6168
20150045411
2015-02-12

Pain treatment

#6169
20150045410
2015-02-12

METHOD OF REGULATING CFTR EXPRESSION AND PROCESSING

#6170
20150044670
2015-02-12

Prostate cancer-specific alterations in ERG gene expression and detection and treatment methods based on those alterations

#6171
20150044239
2015-02-12

Compositions and Methods for Diagnosing, Preventing and Treating Intracranial Aneurysms

#6172
20150044234
2015-02-12

Method of enhancing the efficacy of anti-hepatocyte growth factor receptor breast cancer therapy by administering an inhibitor of mena

#6173
20150044199
2015-02-12

Compositions and methods for treating tumors, fibrosis, and pulmonary alveolar proteinosis

#6174
20150044196
2015-02-12

Compositions for Inhibiting Gene Expression and Uses Thereof

#6175
20150038555
2015-02-05

Extended dicer substrate agents and methods for the specific inhibition of gene expression

#6176
20150038554
2015-02-05

Extended dicer substrate agents and methods for the specific inhibition of gene expression

#6177
20150038551
2015-02-05

Pharmaceutical composition for preventing or treating diabetes containing TENC1 expression or activity suppressor

#6178
20150037427
2015-02-05

Nano delivery systems for siRNA

#6179
20150037401
2015-02-05

siRNA compositions and methods for inhibiting gene expression in tumor initiating cells of breast cancer

#6180
20150037325
2015-02-05

ROBO2 inhibitory compositions comprising SLIT2-binding extracellular domain of ROBO2

#6181
20150031871
2015-01-29

RNA-Mediated Gene Modulation

#6182
20150031856
2015-01-29

Anaplastic lymphoma kinase (ALK) as an oncogene capable of transforming normal human cells

#6183
20150031748
2015-01-29

Modulating the interaction between ZO-2/TJP2 and a Snail zinc finger transcription factor family member

#6184
20150031746
2015-01-29

Methods and compositions for neuroprotection

#6185
20150031745
2015-01-29

Nanoconjugates able to cross the blood-brain barrier

#6186
20150031742
2015-01-29

TREATMENT OF UTERINE LEIOMYOMATA

#6187
20150031622
2015-01-29

RHOGEF12 IS A THERAPEUTIC TARGET FOR THE TREATMENT OF HEART FAILURE

#6188
20150030854
2015-01-29

Vitamin B6-coupled poly(ester amine) as gene carrier and application in cancer gene therapy

#6189
20150030610
2015-01-29

Increasing taxane sensitivity in cancer cells

#6190
20150030605
2015-01-29

POLYPEPTIDES AND POLYNUCLEOTIDES FOR ARTEMIN AND RELATED LIGANDS, AND METHODS OF USE THEREOF

#6191
20150030573
2015-01-29

BACTERIAL MEDIATED THF ALPHA GENE SILENCING

#6192
20150030572
2015-01-29

Identification of molecular pathways and methods of use thereof for treating retinal neurodegeneration and other neurodegenerative disorders

#6193
20150025124
2015-01-22

Compositions and methods for the suppression of target polynucleotides from lepidoptera

#6194
20150025122
2015-01-22

Methods and Compositions for Modulating Gene Expression Using Oligonucleotide Based Drugs Administered in vivo or in vitro

#6195
20150024954
2015-01-22

Aptamer regulated nucleic acids and uses thereof

#6196
20150023973
2015-01-22

Pharmaceutical compositions for preventing or treating angiogenic diseases comprising inhibitors of NUP153 gene expression or NUP153 activity as active ingredient

#6197
20150023968
2015-01-22

Compositions and methods for diagnosing and treating hyperthyroidism in companion animals

#6198
20150020237
2015-01-15

Method for Preparing Fertility-Lowered Plant

#6199
20150020221
2015-01-15

Compositions and methods for the modulation of DNA damage responses using BAL1 and BBAP

#6200
20150018225
2015-01-15

CELL ADHESION INHIBITOR, CELL PROLIFERATION INHIBITOR, AND METHOD AND KIT FOR EXAMINING CANCER

#6201
20150017722
2015-01-15

Double-stranded and single-stranded RNA molecules with 5′ Triphosphates and their use for inducing interferon

#6202
20150017651
2015-01-15

Personalized medicine for the prediction of therapy targeting the hedgehog pathway

#6203
20150017233
2015-01-15

Arginine-based lipids for delivery of therapeutics

#6204
20150017138
2015-01-15

BACTERIAL MEDIATED THF ALPHA GENE SILENCING

#6205
20150017134
2015-01-15

EMT-INDUCING TRANSCRIPTION FACTORS COOPERATE WITH SOX9

#6206
20150011745
2015-01-08

NUCLEIC ACID MOLECULE FOR INHIBITING ACTIVITY OF RNAI MOLECULE

#6207
20150011614
2015-01-08

METHODS AND COMPOSITIONS FOR TREATING INSECTS

#6208
20150011612
2015-01-08

RNAi MODULATION OF RSV AND THERAPEUTIC USES THEREOF

#6209
20150011611
2015-01-08

Inhibition of the glycine cleavage system for treatment of cancer

#6210
20150011610
2015-01-08

Method for enhancing remyelination using GLI1 inhibitors

#6211
20150011608
2015-01-08

iRNA Agents Targeting VEGF

#6212
20150011607
2015-01-08

Methods and compositions for the specific inhibition of alpha-1 antitrypsin by double-stranded RNA

#6213
20150011606
2015-01-08

Compositions and methods to promote erythropoiesis

#6214
20150011605
2015-01-08

Single-Stranded Nucleic Acid Molecule for Controlling Gene Expression

#6215
20150010582
2015-01-08

Methods, kits, and systems for treatment of metastatic papillary thyroid cancer

#6216
20150010502
2015-01-08

Compositions and Methods for Suppressing Gene Expression of p53 and Clusterin

#6217
20150007419
2015-01-08

Cottonseed oil and uses

#6218
20150005370
2015-01-01

Use of human NLK gene and associated drugs thereof

#6219
20150005367
2015-01-01

ADAM12 inhibitors and their use against inflammation-induced fibrosis

#6220
20150005364
2015-01-01

High-efficiency nanoparticle-type double-helical oligo-RNA structure and method for preparing same

#6221
20150005362
2015-01-01

Methods and compositions for reducing viral genome amounts in a target cell

#6222
20150004695
2015-01-01

Lipid particle, nucleic acid transfer carrier, compound for manufacturing nucleic acid transfer carrier, method for manufacturing lipid particle, and gene transfer method

#6223
20150004691
2015-01-01

Novel shRNA Molecules and Methods of Use Thereof

#6224
20150004656
2015-01-01

Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same

#6225
20150004221
2015-01-01

Methods and compositions involving miRNA and miRNA inhibitor molecules

#6226
20150004148
2015-01-01

METHODS AND COMPOSITIONS FOR INCREASING RNA INTERFERENCE

#6227
20140380528
2014-12-25

Simultaneous gene silencing and suppressing gene silencing in the same cell

#6228
20140378667
2014-12-25

Transgenic plants modified for reduced cadmium transport, derivative products, and related methods

#6229
20140378536
2014-12-25

Transcriptional repression leading to parkinson's disease

#6230
20140378531
2014-12-25

INHIBITION OF PATTERN RECOGNITION RECEPTORS IN PANCREATIC CANCER TREATMENT USING TLR INHIBITORS

#6231
20140378530
2014-12-25

Retinaldehyde mimetics and inhibitors of retinaldehyde dehydrogenase I in the treatment of disorders

#6232
20140378529
2014-12-25

Collateral gene inactivation biomarkers and targets for cancer therapy

#6233
20140378526
2014-12-25

DESIGN OF NUCLEIC ACID BINDING MOLECULES WITH NON-WATSON CRICK AND NON-CANONICAL PAIRING BASED ON ARTIFICIAL MUTATION CONSENSUS SEQUENCES TO COUNTER ESCAPE MUTATIONS

#6234
20140378525
2014-12-25

MATERIALS AND METHODS FOR TREATING PTEN MUTATED OR DEFICIENT CANCER

#6235
20140377309
2014-12-25

Agonists and antagonists of toll-like receptor (TLR) 13

#6236
20140377277
2014-12-25

Treatment of vasculoproliferative conditions with Lrg1 antagonists

#6237
20140377266
2014-12-25

Methods and compositions involving NKG2D inhibitors and cancer

#6238
20140373199
2014-12-18

Polypeptides having beta-xylosidase activity and polynucleotides encoding same

#6239
20140373197
2014-12-18

dsRNA as insect control agent

#6240
20140373196
2014-12-18

Method to trigger RNA interference

#6241
20140371439
2014-12-18

Double-stranded RNA compounds to CASP2 and uses thereof

#6242
20140371298
2014-12-18

Prevention and treatment of Nosema disease in bees

#6243
20140371295
2014-12-18

Methods and compositions to protect aquatic invertebrates from disease

#6244
20140371294
2014-12-18

Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activities

#6245
20140371293
2014-12-18

Amine cationic lipids and uses thereof

#6246
20140370597
2014-12-18

RNA interference for the treatment of gain-of-function disorders

#6247
20140370027
2014-12-18

INHIBITION OF MACROPHAGE-SYNTHESIZED WNT7B TO INHIBIT TUMOR ANGIOGENESIS AND METASTASIS

#6248
20140370009
2014-12-18

Therapeutic nanoparticles and methods of use thereof

#6249
20140369999
2014-12-18

Screening method

#6250
20140364485
2014-12-11

Methods and compositions for the treatment of cancer

#6251
20140364484
2014-12-11

COMBINATION THERAPY FOR TREATING HEARING AND BALANCE DISORDERS

#6252
20140363448
2014-12-11

CDCP1 AND BREAST CANCER

#6253
20140357700
2014-12-04

Methods and compositions for the specific inhibition of gene expression by double-stranded RNA

#6254
20140357696
2014-12-04

RNAi-related inhibition of TNF alpha signaling pathway for treatment of ocular angiogenesis

#6255
20140357695
2014-12-04

RNAi-mediated inhibition of spleen tyrosine kinase-related inflammatory conditions

#6256
20140357694
2014-12-04

RNAi-mediated inhibition of tumor necrosis factor α-related conditions

#6257
20140357693
2014-12-04

Metabolic gene mesenchymal signatures and uses thereof

#6258
20140357692
2014-12-04

RNAi Inhibition of Serum Amyloid A For Treatment of Glaucoma

#6259
20140356413
2014-12-04

Method for treating fibrosis using siRNA and a retinoid-lipid drug carrier

#6260
20140351961
2014-11-27

COMPOSITIONS AND METHODS FOR TREATMENT OF METASTATIC CANCER

#6261
20140350232
2014-11-27

siRNA conjugate and preparation method thereof

#6262
20140350086
2014-11-27

Methods and compositions involving miRNA and miRNA inhibitor molecules

#6263
20140350082
2014-11-27

Peptide sequence design and use thereof for peptide-mediated siRNA delivery

#6264
20140350079
2014-11-27

Small interference RNAs, uses thereof and method for inhibiting the expression of plk1 gene

#6265
20140350077
2014-11-27

Amphipathic co-oligomers for the delivery of siRNA

#6266
20140350075
2014-11-27

Compositions and methods for inhibiting expression of the PCSK9 gene

#6267
20140350074
2014-11-27

Extended dicer substrate agents and methods for the specific inhibition of gene expression

#6268
20140350073
2014-11-27

Double-stranded nucleic acid molecule, cancer cell proliferation inhibitor and pharmaceutical agent suitable for prevention or treatment of cancer

#6269
20140350072
2014-11-27

Repressor on IFN-λ promoter and siRNA against ZEB1 and BLIMP-1 to increase IFN-λ gene activity

#6270
20140350071
2014-11-27

Serapina1 iRNA compositions and methods of use thereof

#6271
20140350068
2014-11-27

RTP801L SIRNA COMPOUNDS AND METHODS OF USE THEREOF

#6272
20140349401
2014-11-27

Feeder-free Derivation of human-induced pluripotent stem cells with synthetic messenger RNA

#6273
20140349390
2014-11-27

IN VIVO DELIVERY OF NUCLEIC ACIDS TO THE LIVER OR LIVER TISSUE

#6274
20140348901
2014-11-27

COMBINATORIAL METHODS AND COMPOSITIONS FOR TREATMENT OF MELANOMA

#6275
20140348893
2014-11-27

RNAi for the control of insects and arachnids

#6276
20140348882
2014-11-27

IN VIVO DELIVERY OF NUCLEIC ACIDS TO THE LIVER OR LIVER TISSUE

#6277
20140348840
2014-11-27

Method of treating and reducing the risk of acute myelogenous leukemia

#6278
20140343126
2014-11-20

RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (SINA)

#6279
20140343125
2014-11-20

Oligonucleotides for RNA interference and biological applications thereof

#6280
20140343124
2014-11-20

Method for reducing expression of downregulated in renal cell carcinoma in malignant gliomas

#6281
20140343122
2014-11-20

Compositions and methods for inhibiting expression of factor VII gene

#6282
20140343120
2014-11-20

METHODS AND COMPOSITIONS FOR REDUCING ACTIVITY OF THE ATRIAL NATRIURETIC PEPTIDE RECEPTOR AND FOR TREATMENT OF DISEASES

#6283
20140342453
2014-11-20

Combined hairpin-antisense compositions and methods for modulating expression

#6284
20140341908
2014-11-20

METHODS AND COMPOSITIONS TO MODULATE ANTIVIRAL AND IMMUNE ACTIVITY RESPONSES

#6285
20140341877
2014-11-20

MCPIP as wound therapy

#6286
20140336371
2014-11-13

siRNA molecule for inhibiting growth of melanin and application thereof

#6287
20140336370
2014-11-13

Oligomeric compounds and compositions for use in modulation of small non-coding RNAs

#6288
20140336243
2014-11-13

Lipid Formulated Compositions and Methods for Inhibiting Expression of Eg5 and VEGF Genes

#6289
20140336202
2014-11-13

Methods of identifying and using MDM2 inhibitors

#6290
20140336111
2014-11-13

Therapeutic use of activators of zinc finger protein GL13

#6291
20140335530
2014-11-13

Compositions and methods for modulating an immune response

#6292
20140335192
2014-11-13

DELIVERY OF RNA INTERFERING AGENTS

#6293
20140335112
2014-11-13

NOVEL DOUBLE-STRANDED RIBONUCLEIC ACIDS WITH RUGGED PHYSICO-CHEMICAL STRUCTURE AND HIGHLY SPECIFIC BIOLOGIC ACTIVITY

#6294
20140335106
2014-11-13

Methods and pharmaceutical compositions for treating cancer

#6295
20140331342
2014-11-06

Culicinae mosquito Tra-2 RNA interference technique to genetically produce maleness population

#6296
20140329886
2014-11-06

Single-stranded nucleic acid molecule having amino acid backbone

#6297
20140329885
2014-11-06

Lipids, lipid complexes and use thereof

#6298
20140329882
2014-11-06

Oligomeric compounds and compositions for use in modulation of small non-coding RNAS

#6299
20140329880
2014-11-06

Exonuclease resistant polynucleotide and related duplex polynucleotides, constructs, compositions, methods and systems

#6300
20140329878
2014-11-06

Oligonucleotide modulators of the toll-like receptor pathway